Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harvard Catalyst Profiles is currently experiencing a partial system outage. Login/Edit modules are currently disabled.

Lucas Burton Cofer, M.D.

Concepts (9)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Lucas Cofer's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Lucas Cofer has written about over time.
Antihypertensive Agents, 1 publications between 2022 and 2022, average publication date August 2022. Aspirin, 1 publications between 2022 and 2022, average publication date August 2022. Cardiovascular Diseases, 1 publications between 2022 and 2022, average publication date August 2022. Cholesterol, 1 publications between 2022 and 2022, average publication date August 2022. Humans, 1 publications between 2022 and 2022, average publication date August 2022. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2022 and 2022, average publication date August 2022. Lipoproteins, LDL, 1 publications between 2022 and 2022, average publication date August 2022. Platelet Aggregation Inhibitors, 1 publications between 2022 and 2022, average publication date August 2022. Primary Prevention, 1 publications between 2022 and 2022, average publication date August 2022.

To see the data from this visualization as text, click here.
Cofer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (9)
Explore
_
Co-Authors (1)
Explore
_
Similar People (56)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.